BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27073199)

  • 1. Long-Term Renal Outcomes after Cisplatin Treatment.
    Latcha S; Jaimes EA; Patil S; Glezerman IG; Mehta S; Flombaum CD
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1173-1179. PubMed ID: 27073199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.
    Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD
    PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal function.
    Karaboyun K; İriağaç Y; Çavdar E; Avci O; Şeber ES
    J Cancer Res Ther; 2024 Jan; 20(1):144-149. PubMed ID: 38554312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
    van der Vorst MJDL; Neefjes ECW; Toffoli EC; Oosterling-Jansen JEW; Vergeer MR; Leemans CR; Kooistra MP; Voortman J; Verheul HMW
    BMC Cancer; 2019 Nov; 19(1):1066. PubMed ID: 31703649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
    McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
    Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
    Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
    BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.
    Ishitsuka R; Miyazaki J; Ichioka D; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Matsui Y; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Kawai K; Nishiyama H
    Clin Exp Nephrol; 2017 Aug; 21(4):732-740. PubMed ID: 27565169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
    Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
    BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Equations To Estimate Glomerular Filtration Rate and Their Impact on Frequency of Cisplatin-associated Acute Kidney Injury.
    Motwani SS; Choueiri TK; Partridge AH; Hu J; Kaymakcalan MD; Waikar SS; Curhan GC
    Kidney360; 2021 Feb; 2(2):205-214. PubMed ID: 35373014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy.
    Faig J; Haughton M; Taylor RC; D'Agostino RB; Whelen MJ; Porosnicu Rodriguez KA; Bonomi M; Murea M; Porosnicu M
    Am J Clin Oncol; 2018 May; 41(5):432-440. PubMed ID: 27281266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin.
    Patimarattananan T; Nongnuch A; Pattaranutaporn P; Unwanatham N; Jiarpinitnun C; Ngamphaiboon N
    Support Care Cancer; 2021 Feb; 29(2):877-887. PubMed ID: 32524284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study.
    Iwakura T; Fukasawa H; Kitamura A; Ishibuchi K; Yasuda H; Furuya R
    PLoS One; 2020; 15(2):e0229377. PubMed ID: 32084231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after acute kidney injury requiring dialysis: long-term follow up.
    Duran PA; Concepcion LA
    Hemodial Int; 2014 Oct; 18 Suppl 1():S1-6. PubMed ID: 25330825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
    Klöckl MC; Kasparek AK; Riedl JM; Moik F; Mollnar S; Stotz M; Szkandera J; Terbuch A; Gerger A; Niedrist T; Pichler M; Bauernhofer T; Schilcher G; Zitta S; Rosenkranz AR; Friedl C; Stöger H; Posch F
    Sci Rep; 2020 Jul; 10(1):11219. PubMed ID: 32641710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma.
    Mense ES; Smit AAJ; Crul M; Franssen EJF
    J Clin Pharm Ther; 2019 Apr; 44(2):249-257. PubMed ID: 30578577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued monitoring of acute kidney injury survivors might not be necessary in those regaining an estimated glomerular filtration rate >60 mL/min at 1 year.
    Stoumpos S; Mark PB; McQuarrie EP; Traynor JP; Geddes CC
    Nephrol Dial Transplant; 2017 Jan; 32(1):81-88. PubMed ID: 28391314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in decline in renal function due to cisplatin after a short or long hydration scheme in non-small-cell lung cancer: A retrospective cohort study (HYCIS-XL).
    Niggebrugge-Mentink KL; Beex-Oosterhuis MM; Ter Horst PGJ; van de Poll MEC; Dieleman HG; van Kesteren C
    J Clin Pharm Ther; 2020 Oct; 45(5):1153-1158. PubMed ID: 32533904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.
    Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
    Eur J Cancer; 2009 Dec; 45(18):3213-9. PubMed ID: 19850470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery.
    Hakeam HA; Breakiet M; Azzam A; Nadeem A; Amin T
    Ren Fail; 2014 Nov; 36(10):1486-91. PubMed ID: 25155314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cisplatin-induced acute kidney injury on long-term renal function in patients with solid tumors.
    Hino A; Muto S; Shimada Y; Hori S; Isotani S; Nagata M; Horie S
    Clin Exp Nephrol; 2023 Jun; 27(6):506-518. PubMed ID: 36941500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.